Aaron Rosenberg
Net worth: 9 M $ as of 2026-06-29
Net worth: 9 M $ as of 2026-06-29
Aaron Rosenberg is currently Treasurer, Director & Senior Vice President at ArQule, Inc., Treasurer, Director & Senior Vice President at Acceleron Pharma, Inc. since 2021, Treasurer & Director at Harrisvaccines LLC, Treasurer, Director & Senior Vice President at Imago BioSciences, Inc. since 2023, Director at Prometheus Biosciences, Inc. since 2023, and Chief Financial Officer at BeOne Medicines Ltd. since 2024.
Formerly, Mr. Rosenberg was Treasurer & Senior Vice President at Merck & Co., Inc. from 2018 to 2024.
Education includes an MBA from The Leonard N Stern School of Business and an undergraduate degree from Warrington College of Business Administration.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0.03% | 2026-06-10 | 397,891 ( 0.03% ) | 9 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| BEIGENE LTD | Director of Finance/CFO | 2024-07-21 |
| ARQULE, INC. | Director/Board Member | - |
| ACCELERON PHARMA INC. | Director/Board Member | 2021-11-18 |
| IMAGO BIOSCIENCES, INC. | Director/Board Member | 2023-01-10 |
| PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 2023-06-15 |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Treasurer | 2024-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warrington College of Business Administration
Warrington College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions